L’Agenzia Italiana del Farmaco rende disponibili on line nuove ed importanti informazioni su Claritromicina Ranbaxy 125 mg/5 ml - 250 mg/5 ml granulato per sospensione orale.
Ottawa, Ontario — Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Ron Goeree, Director of the PATH Research Institute and an associate professor at McMaster University, is the 2012 recipient of the Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment (HTA).
Ottawa, Ontario — Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Ron Goeree, Director of the PATH Research Institute and an associate professor at McMaster University, is the 2012 recipient of the Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment (HTA).
Revised drug label clarifying dosing and warning recommendations.
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed importanti informazioni riguardanti la temporanea carenza del medicinale Mircera (metossipolietilenglicole-epoetina beta).
Risk of embolization/infarction to organs and potential organ complications.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei Medicinali (EMA), rende disponibili on line nuove ed importanti controindicazioni sui medicinali Protelos/Osseor (ranelato di stronzio).
Reports of eye infections in patients who were given Brilliant Blue G during eye surgeries.
L’Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei Medicinali (EMA), rende disponibili on line nuove ed importanti informazioni su Samsca (tolvaptan).
Disponibili on line nuove e importanti informazioni sui processi di produzione per i medicinali Caelyx (doxorubicina cloridrato) e Ceplene (istamina dicloridrato)
80.211.154.110
